Market Performance - The Hang Seng Index closed at 26,059.85, down 2.1%, while the Hang Seng China Enterprises Index fell 1.8% to 8,701.91[1] - Total turnover in Hong Kong stocks was HKD 3,577 million, a decrease of 24.0% from HKD 2,884 million last Friday[1] - Energy, materials, and utilities sectors rose by 4.0%, 3.1%, and 0.1% respectively, while healthcare, financials, and consumer discretionary sectors fell by 3.4%, 3.3%, and 3.1% respectively[1] Stock Highlights - Xinyi Glass (868 HK) and China Hongqiao (1378 HK) led the gainers, rising by 12.4% and 7.2% respectively[1] - JD Health (6618 HK) and HSBC Holdings (5 HK) were the biggest losers, both down by 5.2%[1] Geopolitical Impact - Recent attacks by the US and Israel on Iran have heightened geopolitical tensions, affecting traditional energy supplies[2] - WTI crude oil prices rose to nearly USD 70, still below the USD 100-115 range seen during the 2022 Russia-Ukraine conflict[2] - Gold prices increased to USD 5,300, reflecting market reactions to the geopolitical situation[2] Sector Analysis - The "Big Three" oil companies saw stock increases between 2.6% and 5.6%, while gold mining stocks like Zhaojin Mining (1818 HK) rose by 6.0%[2] - Airline stocks, including Cathay Pacific (293 HK) and Air China (753 HK), declined by 4.1% to 5.3%[2] Economic Indicators - The US ISM Manufacturing PMI for February was reported at 52.4, slightly down from January's 52.6 but above the market expectation of 51.8[3] Automotive Sector - BYD (1211 HK) reported a 35.8% year-on-year decline in sales for the first two months of 2026, while its stock rose by 4.4%[4] - Geely (175 HK) saw a 1% increase in sales but its stock fell by 2.4%[4] Healthcare Sector - The Hang Seng Healthcare Index dropped by 3.4%, with Hansoh Pharmaceutical (3692 HK) only declining by 1.7%[5] - A clinical study confirmed Hansoh's core product, Fulaimei, showed significant improvements in blood sugar levels and weight loss in patients with severe obesity and type 2 diabetes[5]

Core Viewpoint - Switzerland's export engine is stabilizing, primarily driven by the pharmaceutical sector, with a reported 1.9% growth in the fourth quarter contributing to a 0.2% increase in GDP adjusted for major sporting events [1][2]. Economic Growth - The fourth quarter's GDP growth of 0.2% aligns with initial estimates, while the previous quarter's economic contraction was revised from 0.5% to 0.4%, indicating a milder economic downturn than previously anticipated [1][2]. - Excluding revenues related to major sporting events, the GDP growth would have been only 0.1%, suggesting that while growth has resumed, it remains modest and may depend on the sustainability of trade conditions [1][2]. Pharmaceutical Sector - The pharmaceutical and chemical manufacturing sectors were key contributors to the economic growth, achieving a 1.9% increase in the fourth quarter [1][2]. Trade Agreements and Legal Developments - The economic recovery coincided with a trade agreement between Switzerland and the United States, which may help stabilize the economy that heavily relies on cross-border demand [1][2]. - A recent Supreme Court ruling that overturned the legal basis for tariffs imposed by Donald Trump increases the likelihood of Swiss companies receiving refunds for previously paid taxes, which could be significant for investors assessing the profitability of export-driven industries [1][2].

Group 1 - The UK government is considering the possibility of retaliatory tariffs against the US but prefers to negotiate behind the scenes with the Trump administration [2][3] - Bridget Phillipson emphasized the importance of maintaining a favorable position for the UK and expressed hope for the continuation of preferential tariff agreements with the US [2][3] - The recent announcement of a 15% global tariff by President Trump has raised questions about the validity of previous agreements made with the UK [2][4] Group 2 - The US Supreme Court's ruling against the previous import tariffs imposed by Trump represents a significant setback for his economic agenda [4] - Trump announced a new 10% tariff on all goods entering the US, which he later increased to 15%, raising concerns about the impact on UK trade agreements [4] - UK officials believe that the new tariffs will not affect most of the existing trade agreements with the US, including those related to steel, automotive, and pharmaceuticals [4]

Core Viewpoint - International sugar prices have fallen for four consecutive weeks, reaching their lowest level in over five years, driven by a shift in consumer demand towards high-protein foods due to weight loss medications [1][3]. Group 1: Sugar Consumption Trends - Sugar consumption in the U.S. and other wealthy economies is declining more than expected, while demand growth in developing countries is also below previous forecasts [2]. - The introduction of GLP-1 weight loss injections has significantly reduced users' cravings for sweetness, becoming a key factor in suppressing sugar consumption [3]. - The USDA has revised its forecast for sugar usage in 2026 down by 23,000 tons to 12.3 million tons, attributing this to a decrease in consumer demand [3]. Group 2: Impact of GLP-1 Medications - The prevalence of GLP-1 medications in certain regions of the U.S. is suspected to be a contributing factor to the decline in sugar consumption [4]. - The top 20% of consumers account for approximately 65% of sales for products like cookies and ice cream, indicating that if these "super users" start using GLP-1 medications, sales could decline non-linearly [4]. - As the cost of these medications decreases and their usage expands, their impact on sugar consumption is expected to grow [4]. Group 3: Market Dynamics - Despite the decline in sugar prices, there are no immediate signs of reduced supply due to the long-term investment required for sugarcane cultivation and government subsidies protecting many farmers [6]. - The market sentiment is extremely bearish, with short positions on sugar prices nearing a five-year high [6]. - In contrast to the sugar market, high-protein products have seen significant price increases, driven by rising demand for protein-rich foods [6]. Group 4: Consumer Behavior and Industry Response - The demand for high-protein foods has surged, with cottage cheese sales in the UK increasing by 50% year-on-year [6]. - Food companies are adapting to this shift by reformulating products and enhancing nutritional density rather than solely focusing on sales growth [7]. - This trend is viewed as a long-term industry shift, emphasizing the importance of each bite as consumers eat less [7].

Group 1 - The core point of the news is that a trade agreement has been reached between the US and India, resulting in a significant reduction of tariffs on Indian goods from 50% to 18%, contingent upon India ceasing oil purchases from Russia and increasing imports from the US [2][4] - Modi's response to the agreement indicates acceptance of some US demands, particularly regarding tariff reductions, while remaining ambiguous about the commitment to stop purchasing Russian oil [2][4] - The reduction in tariffs is expected to benefit India's key industries, such as textiles and pharmaceuticals, which have suffered from high tariffs, allowing them to regain access to the US market [6] Group 2 - The trade agreement reflects a shift in India's foreign policy, as it has previously resisted US pressure to stop buying Russian oil, indicating a compromise based on economic interests [4][6] - Trump's comments suggest that the US-India relationship is improving, with the cessation of Russian oil purchases being a significant factor in this assessment [8] - The situation highlights the complex dynamics of international relations, where economic benefits can lead to perceived betrayals, as seen in India's dealings with Russia [8]

Group 1 - UK Prime Minister Starmer emphasizes that engaging with China aligns with the national interests of the UK and aims to foster a more mature relationship between the two countries [1][2] - The UK delegation accompanying Starmer includes over 50 executives and representatives from various sectors such as finance, pharmaceuticals, manufacturing, and culture, highlighting the UK's strengths [1] - Starmer's visit marks the first time in eight years that a UK Prime Minister has visited China, indicating a significant diplomatic engagement [3] Group 2 - The Chinese Foreign Ministry expresses willingness to enhance political mutual trust and deepen practical cooperation with the UK, viewing Starmer's visit as an opportunity for a new chapter in Sino-British relations [2]

Core Viewpoint - Charoen Pokphand Group (CP Group) has significantly contributed to China's economic development over the past 40 years, evolving from a small seed business to a major multinational corporation with extensive investments across various sectors in China [1][3][4]. Group 1: Company History and Development - CP Group was founded in 1921 by a Chinese immigrant, starting as a small seed shop in Bangkok, Thailand, and has since become one of the largest foreign investors in China [2][3]. - The company established its first modern feed factory in Shenzhen in 1979, marking its entry into the Chinese market [3]. - As of 2024, CP Group operates over 670 enterprises in China, employing more than 80,000 people and generating a total revenue of 208 billion RMB [3][4]. Group 2: Investment Strategy and Market Position - CP Group has maintained a strong commitment to investing in China, adapting to market changes and focusing on high-quality development opportunities [4][10]. - The company emphasizes a "three benefits" business philosophy, prioritizing benefits for the country, the people, and the enterprise [4]. - CP Group's investment strategy includes exploring new business models and expanding its product offerings to meet the evolving demands of Chinese consumers [5][10]. Group 3: Innovations and New Business Models - CP Group is leveraging technology in its operations, such as using smart robotics in egg production, which allows one person to manage 168,000 chickens [5]. - The company is diversifying its product range to include health-oriented options like DHA eggs and selenium-enriched eggs, responding to consumer trends [5][6]. - CP Group is also exploring industrial tourism by transforming its egg production facilities into educational and tourist attractions [5][6]. Group 4: Cultural and Economic Contributions - CP Group has invested in the Hainan coffee industry, revamping the "Sun River" coffee brand and establishing a cultural park that integrates tourism and coffee production [7][9]. - The company aims to enhance local economies by collaborating with farmers and local governments, creating job opportunities and promoting rural revitalization [6][9]. - CP Group's coffee products have gained international recognition, with exports to Australia underlining its commitment to expanding its global footprint [9].

Group 1 - European executives at the Davos World Economic Forum warned that internal issues must be resolved to avoid being sidelined in global competition [1][4] - Key problems identified include excessive regulation, bureaucratic inefficiencies, and the failure to effectively utilize the unified market of approximately 450 million people in Europe [1][4] - Executives called for a unified approach and resource integration to enhance overall competitiveness in various future industries [1][4] Group 2 - The forum gathered over 800 global executives, highlighting urgent topics such as high energy costs, the AI race, and supply chain security [2][6] - Fincantieri CEO Pierroberto Folgiero criticized the inefficiency of building separate naval vessels for different countries, emphasizing the need for shared platforms and projects [2][5] - The competitive landscape is intensifying due to factors like the US-China trade war and pressures on key industrial sectors, necessitating a change in narrative for Europe's economic growth and social cohesion [2][5] Group 3 - Novartis CEO Vas Narasimhan noted that European countries are facing obstacles in launching innovative drugs due to US pressure on drug prices [6] - He emphasized that Europe must improve its investment attractiveness to compete with the US, where Novartis is investing billions in new factories and R&D [3][6] - Folgiero pointed out the need for self-sufficiency in strategic sectors like energy and defense, indicating that supply chains will need to become shorter [3][6]

Core Viewpoint - The Swiss Franc (CHF) is experiencing a strong yet constrained trading pattern against the US Dollar (USD) and Euro, driven by the Swiss National Bank's (SNB) zero interest rate policy and global risk sentiment fluctuations, with expectations that the zero interest rate will persist until the second half of 2027 [1][2]. Group 1: Swiss National Bank Policy - The SNB has maintained a policy interest rate of 0%, with no immediate plans to shift to negative rates, even in the face of potential short-term deflation [1][2]. - The SNB's policy is designed to alleviate pressure on key export sectors such as watchmaking and pharmaceuticals, which are facing challenges, including a 7.3% year-on-year decline in watch exports as of November 2025 [1][2]. Group 2: Economic Indicators and Forecasts - The Swiss economy is projected to see GDP growth slow from 1.2% in 2025 to 1.0% in 2026, with a rise in unemployment from 2.8% to 3.0%, indicating insufficient recovery momentum [2]. - Inflation is expected to remain low, with the Consumer Price Index (CPI) nearing 0% at the end of 2025, and the SNB forecasts inflation to rise to 0.3%-0.6% in 2026-2027, within the target range of 0%-2% [1][2]. Group 3: Currency Dynamics and Market Sentiment - The USD/CHF exchange rate is under pressure due to narrowing interest rate differentials, with the market anticipating a 50 basis point rate cut from the Federal Reserve in 2026, delaying the first cut until June [2]. - The CHF continues to attract safe-haven flows amid global uncertainties, including trade tensions and geopolitical conflicts, despite temporary outflows following signals of reduced geopolitical risks from events like the Davos Forum [2]. Group 4: Technical Analysis and Market Outlook - The USD/CHF is expected to trade within a range of 0.79-0.81 throughout 2026, with key resistance levels at 0.8010-0.8020 and support at 0.7970 [3][4]. - The SNB's foreign exchange interventions, the Federal Reserve's interest rate decisions, and global geopolitical risks will be critical factors influencing the CHF's performance [4].

Core Viewpoint - The earnings season is gaining momentum as major publicly traded companies report quarterly financial results, with a focus on four Dow Jones Industrial Average companies this week and their potential impact on the SPDR Dow Jones Industrial Average ETF (DIA) [1] Group 1: Earnings Reports - 3M Company reported earnings, missing revenue expectations but beating earnings per share (EPS) estimates, marking its first revenue miss after seven consecutive beats [3][4] - Johnson & Johnson is expected to report EPS of $2.48 and revenue of $24.15 billion, both showing year-over-year growth, continuing its trend of beating EPS estimates for over 10 quarters [5][6] - Travelers is anticipated to report EPS of $8.60 and revenue of $11.65 billion, both lower than the previous year's figures, while maintaining a strong track record of beating analyst estimates [9][10] - Procter & Gamble is projected to report EPS of $1.87 and revenue of $22.27 billion, with a focus on consumer shopping trends and health, despite a slight decline in EPS expectations [11][12] Group 2: Company Performance and Stock Movements - 3M's stock fell 7.8% to $155.84, with a 52-week range of $121.98 to $174.69, while being up 5.4% over the last year [4] - Johnson & Johnson's stock trades near all-time highs at $217.89, reflecting a 47.1% increase over the past 52 weeks [8] - Travelers shares are priced at $270.57, up 13.1% over the last year, with a 52-week range of $230.42 to $296.85 [10] - Procter & Gamble's shares are down 9.3% over the last 52 weeks, trading at $146.72 with a range of $137.62 to $179.99 [13] Group 3: ETF Impact - The earnings from the four companies are expected to create volatility in ETFs like DIA, which is currently trading at $484.45, up 10.8% over the past year [14][15]